PIM3 and neoplasm: This study enrolled 175 patients with pathologically confirmed rectal cancer who received neoadjuvant chemoradiotherapy; of these, 130 patients demonstrated Pim-3 expression in the primary tumor, while 45 patients were negative for Pim-3 expression (Table 1 and Fig. 1a).